intraductal papillary mucinous neoplasm with branch pancreatic duct type
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who diagnosed with BD-IPMN by imaging or oral choledochoscopy; 2, age =18 years old; 3. Patients who accepted our diagnosis and treatment methods voluntarily, and signed informed consent before surgery; 4, Patients were no high risk factors; 5. Patients with high risk factors refused radical treatment.
Exclusion criteria
Exclusion criteria: 1.Patients who agreed to radical resection due to high risk factors; 2.Patients with severe organ dysfunction, unable to tolerate surgical operations; 3. Tissue biopsy indicates cancer; 4. The gastrointestinal tract of patients were stenosis and distortion and duodenoscope could not pass; 5. Patients with pancreatic duct stenosis that transoral choledochoscope could not pass or reach the lesion site; 6. Patients found to be MD-IPMN or combined MD-IPMN during the operation; 7. Patients who refuse to participate or withdraw from this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Therapeutic effective rate;Tumor recurrence rate;treatment failure rate;Adverse event rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of operations;treatment cost;average stay; | — |
Countries
China
Contacts
The First Affiliated Hospital of Chongqing Medical University